ATE484587T1 - Ldcam genannte moleküle - Google Patents

Ldcam genannte moleküle

Info

Publication number
ATE484587T1
ATE484587T1 AT99942039T AT99942039T ATE484587T1 AT E484587 T1 ATE484587 T1 AT E484587T1 AT 99942039 T AT99942039 T AT 99942039T AT 99942039 T AT99942039 T AT 99942039T AT E484587 T1 ATE484587 T1 AT E484587T1
Authority
AT
Austria
Prior art keywords
ldcam
molecules called
polypeptides
purified
compositions
Prior art date
Application number
AT99942039T
Other languages
English (en)
Inventor
Peter Baum
William Fanslow
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE484587T1 publication Critical patent/ATE484587T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Vending Machines For Individual Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT99942039T 1998-08-07 1999-08-05 Ldcam genannte moleküle ATE484587T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9567298P 1998-08-07 1998-08-07
PCT/US1999/017905 WO2000008158A2 (en) 1998-08-07 1999-08-05 Molecules designated ldcam

Publications (1)

Publication Number Publication Date
ATE484587T1 true ATE484587T1 (de) 2010-10-15

Family

ID=22253083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99942039T ATE484587T1 (de) 1998-08-07 1999-08-05 Ldcam genannte moleküle

Country Status (11)

Country Link
US (5) US7402655B2 (de)
EP (1) EP1102848B1 (de)
JP (1) JP4426724B2 (de)
AT (1) ATE484587T1 (de)
AU (1) AU776825B2 (de)
CA (1) CA2337100C (de)
DE (1) DE69942861D1 (de)
ES (1) ES2353637T3 (de)
IL (3) IL140937A0 (de)
NZ (1) NZ510356A (de)
WO (1) WO2000008158A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69942861D1 (de) * 1998-08-07 2010-11-25 Immunex Corp Ldcam genannte moleküle
AU2588000A (en) * 1998-12-02 2000-06-19 Icos Corporation Novel adhesion molecule and methods of use
US7129338B1 (en) 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
EP1067182A3 (de) * 1999-07-08 2001-11-21 Helix Research Institute Sekretorische- oder Membranproteine
EP1222205A4 (de) * 1999-10-18 2004-03-31 Texas Biotechnology Corp Polynukleotide die für menschliche und maus-adhäsionsproteine (bigr) kodieren.
WO2002014557A1 (en) * 2000-08-15 2002-02-21 The Johns Hopkins University School Of Medecine Diagnosis and treatment of tumor-suppressor associated disorders
UY27304A1 (es) * 2001-05-24 2002-12-31 Avanir Pharmaceuticals Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
US20050232896A1 (en) * 2001-10-04 2005-10-20 Herbert Schwarz Cd137 as a proliferation factor for hematopoietic stem cells
JP2006502978A (ja) * 2002-06-17 2006-01-26 ワイス ブチロフィリン４またはｂ７−ｌ１によるｔ細胞活性化阻害
ATE554108T1 (de) * 2003-07-25 2012-05-15 Amgen Inc Verfahren bezüglich ldcam und crtam
ES2625259T3 (es) * 2006-08-29 2017-07-19 Oxford Biotherapeutics Ltd Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón
US8737317B2 (en) * 2008-05-13 2014-05-27 Qualcomm Incorporated Autonomous carrier selection for femtocells
PT2403878T (pt) 2009-03-05 2017-09-01 Squibb & Sons Llc Anticorpos completamente humanos específicos a cadm1
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
WO2014144817A2 (en) 2013-03-15 2014-09-18 Amgen Inc. Inhibitory polypeptides specific to wnt inhibitors
CA2923145C (en) 2013-09-05 2025-09-16 Amgen Inc. MOLECULES CONTAINING FCS AND EXHIBITING PREDICTABLE, UNIFORM AND REPRODUCIBLE GLYCOFORM PROFILES
MX377275B (es) 2014-05-16 2025-03-07 Amgen Inc Ensayo para detectar poblaciones celulares linfocitos t colaboradores 1 (th1) y linfocitos t colaboradores (th2).
US11978336B2 (en) 2015-07-07 2024-05-07 Ilumi Solutions, Inc. Wireless control device and methods thereof
WO2017007926A1 (en) 2015-07-07 2017-01-12 Ilumi Solutions, Inc. Wireless communication methods
AU2018235928B2 (en) 2017-03-14 2023-09-21 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
CN119639849A (zh) 2018-03-26 2025-03-18 美国安进公司 细胞培养物中产生的抗体的总去岩藻糖基化糖型
AU2020355251A1 (en) 2019-09-26 2022-04-21 Amgen Inc. Methods of producing antibody compositions
WO2021247892A1 (en) 2020-06-04 2021-12-09 Amgen Inc. Assessment of cleaning procedures of a biotherapeutic manufacturing process
AU2021360897A1 (en) 2020-10-15 2023-05-25 Amgen Inc. Relative unpaired glycans in antibody production methods
AR126089A1 (es) 2021-06-07 2023-09-13 Amgen Inc Uso de fucosidasa para controlar el nivel de afucosilación de proteínas glucosiladas
WO2023059607A1 (en) 2021-10-05 2023-04-13 Amgen Inc. Fc-gamma receptor ii binding and glycan content
WO2023215725A1 (en) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy
AU2024256160A1 (en) 2023-04-20 2025-10-02 Amgen Inc. Methods of determining relative unpaired glycan content
AU2024325342A1 (en) 2023-08-14 2026-02-26 Amgen Inc. Methods for reducing yellow color
WO2025101820A1 (en) 2023-11-08 2025-05-15 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy
WO2026090253A1 (en) 2024-10-23 2026-04-30 Amgen Inc. Methods of determining glycan pairing content

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032776A2 (en) 1998-12-01 2000-06-08 Genentech, Inc. Secreted amd transmembrane polypeptides and nucleic acids encoding the same
US6642360B2 (en) * 1997-12-03 2003-11-04 Genentech, Inc. Secreted polypeptides that stimulate release of proteoglycans from cartilage
AU736506B2 (en) * 1997-12-03 2001-07-26 Genentech Inc. Polypeptides and nucleic acids encoding the same
US20020165143A1 (en) * 1997-12-03 2002-11-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1999057132A1 (en) 1998-05-07 1999-11-11 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
EP1108042B1 (de) * 1998-08-07 2008-11-26 Immunex Corporation B7l-1 moleküle
DE69942861D1 (de) * 1998-08-07 2010-11-25 Immunex Corp Ldcam genannte moleküle
WO2000029435A1 (en) 1998-10-28 2000-05-25 Human Genome Sciences, Inc. 12 human secreted proteins
WO2001000237A1 (en) 1999-06-30 2001-01-04 Sigma-Aldrich Co. Synthetic peptide immunogens and antibodies thereto
EP1285084A1 (de) 2000-01-25 2003-02-26 Hyseq, Inc. Neuartige nukleinsäure und polypeptide
AU2001296301A1 (en) 2000-09-26 2002-04-08 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies

Also Published As

Publication number Publication date
US7402655B2 (en) 2008-07-22
IL193886A (en) 2010-12-30
IL193886A0 (en) 2009-05-04
WO2000008158A3 (en) 2000-05-11
US7659385B2 (en) 2010-02-09
US20020168712A1 (en) 2002-11-14
ES2353637T3 (es) 2011-03-03
EP1102848B1 (de) 2010-10-13
AU776825B2 (en) 2004-09-23
JP2002523021A (ja) 2002-07-30
JP4426724B2 (ja) 2010-03-03
US20090155845A1 (en) 2009-06-18
CA2337100A1 (en) 2000-02-17
CA2337100C (en) 2011-09-20
NZ510356A (en) 2004-12-24
EP1102848A2 (de) 2001-05-30
US20100215572A1 (en) 2010-08-26
US7741115B2 (en) 2010-06-22
DE69942861D1 (de) 2010-11-25
US20040204568A1 (en) 2004-10-14
US20090011499A1 (en) 2009-01-08
IL140937A0 (en) 2002-02-10
IL140937A (en) 2010-05-31
AU5550399A (en) 2000-02-28
WO2000008158A2 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
DE69942861D1 (de) Ldcam genannte moleküle
ATE415480T1 (de) B7l-1 moleküle
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
ATE184052T1 (de) Gdf-1 und uog1 proteine
DK1482040T3 (da) NL3-TIE-receptortyrosinkinaseligandhomologer
ATE310090T1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
DK1129190T3 (da) Human TSLP DNA og polypeptider
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DK0804558T3 (da) Tripeptidylaminopeptidase
AU7303301A (en) Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
SE9801455D0 (sv) New receptor
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
DE69535316D1 (de) Als lerk6 bezeichnetes cytokin
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
ATE408687T1 (de) Semaphorin polypeptide
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
ZA99445B (en) Isolated, polypeptides which bind to HLA-A29 molecules nucleic acid, the molecules encoding these, and uses thereof.
SE9604439D0 (sv) New receptor
DE69827808D1 (de) Protease-ähnliches protein
HK1031229A (en) Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties